Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector with a promising pipeline and notable analyst support, offering a potential upside of 40.22% based on its..
Surgery Partners, Inc. (NASDAQ: SGRY) has captured the attention of investors with its dynamic presence in the healthcare sector, particularly in the medical care facilities industry. Headquartered in Brentwood, Tennessee,..
Investors eyeing the healthcare sector may find UFP Technologies, Inc. (UFPT) an intriguing opportunity, especially considering its robust growth metrics and potential upside. With a market capitalization of $1.88 billion,..
For investors seeking opportunities in the healthcare sector, Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case. With a market capitalization of $1.11 billion, Pacira BioSciences operates in the competitive..
Neogen Corporation (NASDAQ: NEOG) is making waves in the healthcare sector, particularly within the diagnostics and research industry, with a remarkable potential upside of 56.90%. As investors search for promising..
LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a prominent player in the healthcare sector, specifically within the niche of medical instruments and supplies. Headquartered in Burlington, Massachusetts, this company has carved..
Supernus Pharmaceuticals, Inc. (SUPN), a key player in the healthcare sector, is attracting significant investor attention with a compelling potential upside of 23.73%. This biopharmaceutical company, headquartered in Rockville, Maryland,..
PACS Group, Inc. (PACS) is an intriguing player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $2 billion, PACS Group operates a..
Ardent Health, Inc. (ARDT) is capturing the attention of investors with its promising growth potential, highlighted by a potential upside of 48.74%. As a major player in the healthcare sector,..
Mesoblast Limited (MESO), a biotechnology company headquartered in Melbourne, Australia, is capturing investor attention due to its significant upside potential. With a market capitalization of $1.38 billion and a focus..
Azenta, Inc. (NASDAQ: AZTA) is a noteworthy player in the healthcare sector, focusing on medical instruments and supplies. With a market capitalization of $1.41 billion, the company is positioned as..
Beam Therapeutics Inc. (NASDAQ: BEAM) presents a captivating prospect for investors within the biotechnology sector, particularly given its potential upside of 159.06%. This innovative company, headquartered in Cambridge, Massachusetts, is..
Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is generating buzz among investors with its compelling growth story and a notable potential upside of 31.96%...
For investors eyeing opportunities in the biotechnology sector, ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) presents a compelling case with its focus on the development and commercialization of innovative treatments for central..
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents a compelling opportunity for investors seeking entry into the healthcare sector, particularly in the niche of behavioral healthcare services. With its roots in..
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is emerging as a compelling player in the biotechnology sector, capturing investor attention with its ambitious pipeline and significant growth potential. With a current market..
For investors keeping a keen eye on the biotechnology sector, Ligand Pharmaceuticals Inc. (NASDAQ: LGND) presents an intriguing opportunity. With a market capitalization of $2.19 billion, Ligand is a significant..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company with a focus on rare and ultra-rare genetic diseases, has caught the attention of investors with its robust pipeline and impressive market..
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is currently garnering attention in the biotech sector, a field known for its high-risk, high-reward dynamics. With a market capitalization of $2.69 billion, this clinical-stage..
National HealthCare Corporation (NYSE: NHC), a prominent player in the healthcare sector, is capturing investor attention with an impressive revenue growth of 25.7% and a steady dividend yield of 2.39%...
